• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国放射学领域的卫生技术评估:需求不足,供给不足。

Health Technology Assessments in Radiology in Germany: Lack of Demand, Lack of Supply.

作者信息

Winkelmann Carolin, Neumann Thomas, Zeidler Jan, Prenzler Anne, Vogt Bodo, Wacker Frank K

机构信息

Chair in Empirical Economics, Otto-von-Guericke-University Magdeburg, Germany.

Research Campus STIMULATE, Otto-von-Guericke-University Magdeburg, Germany.

出版信息

Rofo. 2019 Jul;191(7):635-642. doi: 10.1055/a-0838-6253. Epub 2019 Feb 14.

DOI:10.1055/a-0838-6253
PMID:30763963
Abstract

BACKGROUND

Health technology assessments (HTAs) are an interdisciplinary method to support sustainable, evidence-based healthcare decisions. They systematically assess medical products, procedures, and technologies with respect to medical, economic, legal, social, and ethical aspects.

METHOD

This review analyzes the current use of HTAs in radiology in Germany and discusses challenges associated with HTAs. In particular, incentive structures of various players in the healthcare field involved in HTA implementation are considered for both the inpatient and outpatient sectors. Taking into account that the Joint Federal Committee (G-BA) has different authority between sectors ("ban reservation" for inpatients and "authorization right" for outpatients), we focus on the repercussions on reimbursement for new diagnosis or treatment methods by statutory health insurance companies.

RESULTS

The G-BA's authority implicitly creates a paradox in terms of incentives to implement and finance HTAs: in the outpatient sector HTAs are considered necessary to evaluate new medical services while players may not have sufficient incentive to implement and finance HTAs in the inpatient sector.

CONCLUSION

Characteristics of HTAs differ widely with respect to the items to be assessed. Therefore, an HTA for drug effectiveness is not easily transferable to radiological procedures. Within radiology, each method must be assessed individually (e. g. according to tumor stage). Despite these challenges, systematic compilation and critical assessment (regarding both cost and medical effectiveness) of available evidence should be a basic component of evidence-based radiology. As companies in healthcare fail to invest in studies that advance evidence-based radiology and considering the lack of incentive for such investments, public funding institutions need to accept the challenge to support studies that assess the benefit of radiological procedures.

KEY POINTS

· HTAs should be a basic component of evidence-based radiology.. · G-BA's authority implicitly creates a paradox in terms of inventives to implement and finance HTAs.. · University hospitals and public funding institutions need to support studies that assess the benefit of radiological procedures..

CITATION FORMAT

· Winkelmann C, Neumann T, Zeidler J et al. Health Technology Assessments in Radiology in Germany: Lack of Demand, Lack of Supply. Fortschr Röntgenstr 2019; 191: 635 - 642.

摘要

背景

卫生技术评估(HTA)是一种跨学科方法,用于支持可持续的、基于证据的医疗保健决策。它从医学、经济、法律、社会和伦理等方面系统地评估医疗产品、程序和技术。

方法

本综述分析了德国放射学领域HTA的当前使用情况,并讨论了与HTA相关的挑战。特别是,考虑到参与HTA实施的医疗保健领域各参与者的激励结构,涵盖了住院和门诊部门。鉴于联邦联合委员会(G-BA)在不同部门有不同的权力(住院患者为“禁止保留”,门诊患者为“授权权”),我们重点关注法定健康保险公司对新诊断或治疗方法报销的影响。

结果

G-BA的权力在实施和资助HTA的激励方面隐含地造成了一个悖论:在门诊部门,HTA被认为是评估新医疗服务所必需的,而在住院部门,参与者可能没有足够的动力来实施和资助HTA。

结论

HTA在待评估项目方面差异很大。因此,药物疗效的HTA不易转化为放射学程序。在放射学领域,每种方法都必须单独评估(例如根据肿瘤分期)。尽管存在这些挑战,但对现有证据进行系统整理和批判性评估(包括成本和医疗效果)应是循证放射学的基本组成部分。由于医疗保健领域的公司未能投资于推进循证放射学的研究,且考虑到缺乏此类投资的激励,公共资助机构需要接受挑战,支持评估放射学程序益处的研究。

关键点

· HTA应是循证放射学的基本组成部分。· G-BA的权力在实施和资助HTA的激励方面隐含地造成了一个悖论。· 大学医院和公共资助机构需要支持评估放射学程序益处的研究。

引用格式

· Winkelmann C, Neumann T, Zeidler J等。德国放射学中的卫生技术评估:需求不足,供应不足。Fortschr Röntgenstr 2019; 191: 635 - 642。

相似文献

1
Health Technology Assessments in Radiology in Germany: Lack of Demand, Lack of Supply.德国放射学领域的卫生技术评估:需求不足,供给不足。
Rofo. 2019 Jul;191(7):635-642. doi: 10.1055/a-0838-6253. Epub 2019 Feb 14.
2
[Health technology assessment (HTA). Developments in healthcare and potential for radiology].[卫生技术评估(HTA)。医疗保健领域的发展及放射学的潜力]
Radiologe. 2014 Jun;54(6):589-98. doi: 10.1007/s00117-014-2695-6.
3
Health technology assessment and primary data collection for reducing uncertainty in decision making.卫生技术评估与原始数据收集以减少决策中的不确定性
J Am Coll Radiol. 2009 May;6(5):332-42. doi: 10.1016/j.jacr.2009.01.012.
4
The Role of Measurement Uncertainty in Health Technology Assessments (HTAs) of In Vitro Tests.测量不确定度在体外诊断检验的卫生技术评估(HTA)中的作用。
Pharmacoeconomics. 2018 Jul;36(7):823-835. doi: 10.1007/s40273-018-0638-1.
5
Individual health services.个人健康服务。
GMS Health Technol Assess. 2011;7:Doc05. doi: 10.3205/hta000096. Epub 2011 Sep 15.
6
Over-, under- and misuse of pain treatment in Germany.德国疼痛治疗的过度、不足及不当使用情况。
GMS Health Technol Assess. 2011 Apr 19;7:Doc03. doi: 10.3205/hta000094.
7
[Health economics and HTA].[卫生经济学与卫生技术评估]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2006 Mar;49(3):257-63. doi: 10.1007/s00103-005-1228-x.
8
[Jurisdictions on the reimbursement of new medical technologies by public health insurance: A systematic review].[公共医疗保险对新医疗技术的报销管辖权:一项系统综述]
Z Evid Fortbild Qual Gesundhwes. 2018 Apr;131-132:8-16. doi: 10.1016/j.zefq.2017.12.004. Epub 2018 Jan 10.
9
Bridging trial and decision: a checklist to frame health technology assessments for resource allocation decisions.桥接试验与决策:用于为资源分配决策制定卫生技术评估的清单。
Value Health. 2011 Jul-Aug;14(5):777-84. doi: 10.1016/j.jval.2011.01.005.
10
Approaches for economic evaluations of health care technologies.医疗保健技术的经济评估方法。
J Am Coll Radiol. 2009 May;6(5):307-16. doi: 10.1016/j.jacr.2009.01.011.

引用本文的文献

1
Evidence-based funding of new imaging applications and technologies by Medicare in Australia: How it happens and how it can be improved.澳大利亚医保对新影像应用和技术的循证资金资助:其实施方式和改进途径。
J Med Imaging Radiat Oncol. 2022 Mar;66(2):215-224. doi: 10.1111/1754-9485.13386.